CLINICAL_TRIALS
trial_result
· 2017-09-13
Clinical Trial Update: Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma [Phase 2]
Summary
Phase 2 clinical trial update for NPI-0052 in relapsed/refractory multiple myeloma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-09-13